The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men

Cited by (244)

Items 101–200 of 244

1. Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy
   Daniel de Souza Ramos Angrimani, Maria Claudia Pereda Francischini, Maíra Morales Brito, Camila Infantosi Vannucchi · 2020 · PLoS ONE
2. Nonsurgical Therapy for Hair Loss
   Aron G. Nusbaum, Paul T. Rose, Bernard P. Nusbaum · 2013 · Facial Plastic Surgery Clinics of North America
3. Androgen levels and apoptosis in the testis during postnatal development of finasteride-treated male rat offspring
   Agnieszka Kolasa, Kamila Misiakiewicz-Has, Irena Baranowska‐Bosiacka, Izabela Gutowska, Barbara Wiszniewska · 2015 · Folia Histochemica et Cytobiologica
4. Sexual Side Effects of Medical and Surgical Benign Prostatic Hyperplasia Treatments
   Charles Welliver, Ahmed Essa · 2016 · Urologic Clinics of North America
5. Androgen and estrogen actions on male physical activity: a story beyond muscle
   Ferran Jardí, Michaël R. Laurent, Vanessa Dubois, Nari Kim, Rougin Khalil, Brigitte Decallonne, Dirk Vanderschueren, Frank Claessens · 2018 · Journal of Endocrinology
6. The post-finasteride syndrome: possible etiological mechanisms and symptoms
   Herman H. J. Leliefeld, Frans M.J. Debruyne, Yacov Reisman · 2023 · International Journal of Impotence Research
7. Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
   Mariah C. Estill, Avery D. Ford, Ruba Omeira, Matthew Rodman · 2023 · Georgetown Medical Review
8. Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia
   Aditya Kumar Gupta, Mesbah Talukder, Greg Williams · 2024 · Expert Opinion on Emerging Drugs
9. Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
   Yunbu Ding, Chaofan Wang, Lingbo Bi, Yimei Du, Changpei Lu, Min Zhao, Weixin Fan · 2024 · Dermatology
10. Effect of 1‐mg Dose of Finasteride on Spermatogenesis and Pregnancy
    Eric L. Laborde, Robert E. Brannigan · 2010 · Journal of Andrology
11. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically
    Camila Bruna de Lima, Daniel de Souza Ramos Angrimani, R. B. Flores, Camila Infantosi Vannucchi · 2020 · Domestic Animal Endocrinology
12. The Chemosensing Role of CatSper in Mammalian Sperm: An Updated Review
    Su-Lun Ke, T. Luo · 2023 · Current Issues in Molecular Biology
13. Male androgenetic alopecia
    Gabriel Lazzeri Cortez, Karime Marques Hassun, Luciana Linhares, Verena Florenço, Maria Valéria Bussamara Pinheiro, Maurício Mendonça do Nascimento · 2025 · Anais Brasileiros de Dermatologia
14. Androgen Synthesis in the Gonadotropin-Suppressed Human Testes Can Be Markedly Suppressed by Ketoconazole
    Mara Yvonne Roth, J. J. Nya‐Ngatchou, K. Lin, S. T. Page, Bradley David Anawalt, Alvin M. Matsumoto, Brett T. Marck, W. J. Bremner, John Kenneth Amory · 2013 · The Journal of Clinical Endocrinology & Metabolism
15. FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction
    Elizabeth R. Rayburn, Liang Gao, Jiayi Ding, Hongxia Ding, Jun Shao, Haibo Li · 2017 · Journal of Assisted Reproduction and Genetics
16. Androgenic Alopecia
    Amber S Tully, Justin Schwartzenberger, James S. Studdiford · 2010 · Journal of Men s Health
17. Ejaculate testosterone levels affect maternal investment in red junglefowl (Gallus gallus gallus)
    Asmoro Lelono, Bernd Riedstra, Ton G. G. Groothuis · 2019 · Scientific Reports
18. Finasteride and fertility: case report and review of the literature.
    Giuseppe Ricci, Monica Martinelli, Stefania Luppi, Leila Lo Bello, Michela De Santis, Kristina Skerk, Gabriella Zito · 2012 · PubMed
19. Medical Treatment for Androgenetic Alopecia
    Ratchathorn Panchaprateep · 2023 · Facial Plastic Surgery
20. Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay
    Joshua F. Yarrow, Darren T. Beck, Christine F. Conover, Luke A. Beggs, Bruce A. Goldberger, Stephen E. Borst · 2013 · Steroids
21. Variability of Semen Parameters with Time in Placebo Treated Men
    Jonathan P. Jarow, Xin Fang, Tarek A. Hammad · 2012 · The Journal of Urology
22. Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
    David Robinson, Hans Garmo, Pär E. Stattin, Karl Michaëlsson · 2015 · PLoS ONE
23. Protective role of hesperidin in finasteride-induced testicular toxicity in adult male Wistar rats: Insights into oxidative stress, apoptosis, and ultrastructure of seminiferous tubules
    Iman Nabil, Amira Abulfotooh Eid, Hend A. Yassin, Rana Abouelrous, Amany A. Solaiman · 2024 · Reproductive Toxicology
24. Effects of Taraxaci Herba (Dandelion) on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats
    Seong Min Lee, Sang Mok Lee, Jungbin Song · 2024 · Nutrients
25. 5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
    David Robinson, Hans Garmo, Lars Holmberg, Pär E. Stattin · 2015 · Cancer Causes & Control
26. Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients
    César Daniel Villarreal‐Villarreal, Estefania Boland‐Rodríguez, S.A. Rodríguez‐León, F. Le voti, Sérgio Vañó-Galván, Rodney Daniel Sinclair · 2022 · Journal of the European Academy of Dermatology and Venereology
27. Paternal drug use: before and during pregnancy
    Ineke Crijns, Jens Bos, M. Knol, Sabine M. J. M. Straus, Lolkje de Jong‐van den Berg · 2012 · Expert Opinion on Drug Safety
28. Première enquête nationale française sur les modes de vie et les facteurs toxiques chez les couples infertiles
    Sylvia Alvarez, Émmanuel Devouche · 2012 · Gynécologie Obstétrique & Fertilité
29. Androgens and prostate cancer risk
    Sara M. Wirén, Pär E. Stattin · 2008 · Best Practice & Research Clinical Endocrinology & Metabolism
30. Is Dihydrotestosterone a Classic Hormone?
    Bradley David Anawalt · 2017 · Endocrine Reviews
31. Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride
    Mara Yvonne Roth, Robert E. Dudley, L. Hull, A. Leung, Peter D. Christenson, C. Wang, Ronald S. Swerdloff, John Kenneth Amory · 2010 · International Journal of Andrology
32. Pharmacokinetics and Pharmacodynamics of Oral Testosterone Enanthate Plus Dutasteride for 4 Weeks in Normal Men: Implications for Male Hormonal Contraception
    John Kenneth Amory, Thomas F. Kalhorn, Stephanie T. Page · 2008 · Journal of Andrology
33. Origanum vulgareL. leaves extract alleviates testis and sperm damages induced by finasteride: Biochemical, Immunohistological and apoptosis genes based evidences
    Xiaoning Chen, Hui Feng, Attalla Farag El-kott, Eman M. Abd‐Ella · 2020 · Andrologia
34. The adverse effects of commonly used medications on male fertility: a comprehensive review
    Armin Ghomeshi, Boris Yang, Thomas A. Masterson · 2023 · F&S Reviews
35. Common urologic diseases in older men and their treatment: how they impact fertility
    Gabriella Avellino, Didi P. Theva, Robert Davis Oates · 2017 · Fertility and Sterility
36. Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature
    Anupam Das, Piyush Kumar, Niharika Ranjan Lal, Sourabh Jain, Anupama Ghosh · 2018 · Indian Journal of Dermatology Venereology and Leprology
37. Long-term treatment with finasteride induces apoptosis and pathological changes in female mice
    AA Alkahtane, Gadah Ibraheem Albasher, NK Al-Sultan, Wedad Saeed Al-Qahtani, Saud A. Alarifi, Rafa Almeer, Jawahir Alghamdi, Daoud Ali, Abeer Alahmari, Saad Hussin Alkahtani · 2019 · Human & Experimental Toxicology
38. Finasteride interferes with prostaglandin-induced CatSper signalling in human sperm
    Michala Rosa Birch, Steen Dissing, Niels Erik Skakkebæk, Anders Rehfeld · 2021 · Reproduction
39. Pharmacokinetics of 2 Novel Formulations of Modified‐Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism
    Christin N. Snyder, Richard V. Clark, Ralph B. Caricofe, Mark Bush, Mara Yvonne Roth, Stephanie T. Page, William J. Bremner, John Kenneth Amory · 2010 · Journal of Andrology
40. Hormonal and Genetic Etiology of Male Androgenetic Alopecia
    Konstantinos Anastassakis · 2022 · Springer eBooks
41. Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
    Abdulmaged M. Traish, Yonah Krakowsky, Gheorghe D. Doros, Abraham Morgentaler · 2018 · Sexual Medicine Reviews
42. Alopecia and techniques in hair restoration: an overview for the cosmetic surgeon
    Rohan R. Joshi, Tom Shokri, Austin T. Baker, Scott Kohlert, Mofiyinfolu Sokoya, Sameep Kadakia, Jeffrey S. Epstein, Yadranko Ducic, Ron Michael Johnson · 2019 · Oral and Maxillofacial Surgery
43. Hair transplantation for men
    Marc R. Avram, Nicole E. Rogers · 2008 · Journal of Cosmetic and Laser Therapy
44. Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content
    Yasuhiro Shibata, Seiji Arai, Yoshiyuki Miyazawa, Takahiro Shuto, Masashi Nomura, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui, Kazuto Ito, Kazuhiro Suzuki · 2017 · The Prostate
45. Effect of Exogenous Medications and Anabolic Steroids on Male Reproductive and Sexual Health
    Jorge Hallak, Thiago Afonso Teixeira, Guilherme Leme de Souza · 2020 · Springer eBooks
46. The association of medications and supplements with human male reproductive health: a systematic review
    Abdullah Alhamam, Laurianne Rita Garabed, Sania Julian, Ryan Kendrick Flannigan · 2023 · Fertility and Sterility
47. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
    Qinghua Fang, Pei-Ya Chen, Ningchao Du, Kutty Selva Nandakumar · 2019 · Clinical Breast Cancer
48. A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia
    Kanika Gupta, Mona Yezdani, Tiffany Sotelo, Jeanny B. Aragon‐Ching · 2015 · Expert Opinion on Investigational Drugs
49. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
    Tony Antoniou, Erin M. Macdonald, Zhan Yao, Tara Gomes, Mina Tadrous, Joanne M.-W. Ho, Muhammad Mamdani, David Nelson Juurlink · 2018 · BMC Musculoskeletal Disorders
50. Physiologie der Hodenfunktion
    Gerhard F. Weinbauer, Craig Marc Luetjens, Manuela Simoni, Eberhard Nieschlag · 2009 · Springer eBooks
51. Benign prostatic hyperplasia and male lower urinary tract symptoms.
    Tom McNicholas, Roger Sinclair Kirby · 2012 · PubMed
52. Preconception Care for Men
    최진호, 한정열 · 2016 · JOURNAL OF THE KOREAN SOCIETY OF MATERNAL AND CHILD HEALTH
53. Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review
    Aditya Kumar Gupta, Mesbah Talukder · 2025 · Expert Opinion on Pharmacotherapy
54. Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters
    Young Jae Kim, Seung Ryeol Lee, Young Dong Yu · 2025 · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine
55. Induction of hair growth in hair follicle cells and organ cultures upon treatment with 30 kHz frequency inaudible sound via cell proliferation and antiapoptotic effects
    Hyangtae Choi, Yonghee Lee, Seung Hyun Shin, Jin Nam, Won-Seok Park, Byung S. Park, Beom Joon Kim · 2022 · Biomedical Reports
56. The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
    Sara Baldini, Ahmed S Khattak, Paolo Capogrosso, Gabriele Antonini, Federico Dehò, Fabrizio Schifano, Nicolò Schifano · 2023 · Brain Sciences
57. Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
    Min-Woo Kim, Hyunsun Park, Jong Seo Park, Seong‐Joon Koh, Soyun Cho · 2017 · Annals of Dermatology
58. Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement
    Takahiro Maeda, Eiji Kikuchi, Masanori Hasegawa, Keiko Homma, Toshiyuki Ando, Kenjiro Suzuki, Gou Kaneko, Ryuichi Mizuno, Akira Miyajima, Mototsugu Oya · 2017 · International Journal of Urology
59. Is Men's Health Just a Single Letter?
    Bradley David Anawalt · 2014 · The Journal of Clinical Endocrinology & Metabolism
60. Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
    Dana M. Otzel, Larissa Nichols, Christine F. Conover, STEPHEN A. MARANGI, Jayachandra R. Kura, Dominic K. Iannaccone, David J. Clark, Chris M. Gregory, Christopher F. Sonntag, Anita Wokhlu et al. · 2024 · Frontiers in Neurology
61. Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site
    Sirus Rabbani, Giola Santoni, Jesper Lagergren, Shao‐Hua Xie · 2022 · British Journal of Cancer
62. Connexin 43 expression in the testes during postnatal development of finasteride-treated male rat offspring
    Agnieszka Kolasa, Kamila Misiakiewicz-Has, Irena Baranowska‐Bosiacka, Izabela Gutowska, Maciej Tarnowski, Marta Tkacz, Barbara Wiszniewska · 2017 · Archives of Medical Science
63. Medical Treatments for Male and Female Pattern Hair Loss
    Nicole E. Rogers, Marc R. Avram · 2010 · Series in cosmetic and laser therapy
64. Alternative Treatment Modalities for the Hypogonadal Patient
    Landon W Trost, Mohit Khera · 2014 · Current Urology Reports
65. Androgen Deficiency Disorders
    Carolyn A Allan, Robert Ian McLachlan · 2010 · Elsevier eBooks
66. Predictivity of Nonclinical Male Reproductive Findings for Human Effects
    Anthony R. Scialli, Richard V. Clark, Robert E. Chapin · 2017 · Birth Defects Research
67. Emotional consequences of male infertility
    Vassili Glazyrine, Dane A. Stephens, EMILY A. WENTZELL, Kimberly Wallace-Young, Ajay K. Nangia · 2021 · Elsevier eBooks
68. Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
    Michael S. Irwig, Jessika Sanz, Deborah A. Lin, Nicholas Tan, Erica D. Dommasch · 2023 · International Journal of Impotence Research
69. Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia
    So Inamura, Yusuke Fukiage, Hisato Kobayashi, Manami Tsutsumiuchi, Masaya Seki, Minekatsu Taga, Masato Fukushima, Motohiro Kobayashi, Osamu Yokoyama, Naoki Terada · 2024 · International Journal of Urology
70. Formulation development and scale-up of dutasteride liquisolid tablets
    Krzysztof Woyna-Orlewicz, Grzegorz Huszcza, Edyta Pesta, Miroslaw M. Strozik, Mateusz Kurek, Agata Antosik, Renata Jachowicz, Przemysław Dorożyński, Aleksander Mendyk · 2025 · Drug Development and Industrial Pharmacy
71. The relevance of experimental reproductive studies in safety assessment
    Jane Stewart · 2017 · Current Opinion in Toxicology
72. Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring—Preliminary Study
    Agnieszka Kolasa, Dorota Rogińska, Sylwia Rzeszotek, Bogusław Machaliński, Barbara Wiszniewska · 2021 · Current Issues in Molecular Biology
73. The Role of Androgens in Prostate Cancer
    Frances M. Alba, Claudio A. Romero, Run Wang · 2012 · Humana Press eBooks
74. Diagnosis and Treatment
    Ralph Michel Trüeb, Won‐Soo Lee · 2013 · Springer eBooks
75. Angiopoietin-1 induces survival and proliferation of hair follicle dermal papilla cells through integrin α5β1 signaling
    Jang-Hyuk Yun · 2025 · Frontiers in Medicine
76. Finasteride and male fertility
    Dilip Gude · 2011 · Journal of Human Reproductive Sciences
77. The Difficult Dermatologic Condition
    Ralph Michel Trüeb · 2015 · Springer eBooks
78. Re: A Prospective Randomised Placebo-controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
    Ignacio Moncada, Pramod Krishnappa · 2018 · European Urology
79. Aberrant Expression Levels of Androgen Receptor and SRD5A2 in Epididymal Epithelial Cells of Crossbred Infertile Cattle–Yak
    Manita Wittayarat, Kimika Kawanishi, Haruka Ohata, Megumi Nagahara, Rentsenkhand Sambuu, Otgonjargal Sambuu, Maki Hirata, Fuminori Tanihara, Masayasu Taniguchi, Takeshige Otoi et al. · 2025 · Animals
80. Effect of Testosterone, Dihydrotestosterone, Estradiol and Cortisol on the Quality of Fresh and Cryopreserved Stallion Sperm
    Анна Михайловна Шитикова, Михаил Михайлович Атрощенко, Lidia V. Krokhotina, Mariya Engalycheva, Дмитриева Мария Николаевна · 2022 · Journal of Experimental Biology and Agricultural Sciences
81. Possibilities and Limitations for Reversal of Age-Related Hair Loss
    Nina Otberg, Isabel Restrepo, Jerry Shapiro · 2010 · Springer eBooks
82. Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?
    Thomas I.S. Hwang · 2011 · Urological Science
83. Clomiphene citrate rescue of spermatogenesis in men with infertility while remaining on finasteride: A case report
    Christopher L. Wu, Ellen Forbes, Keith Allen Jarvi · 2017 · Canadian Urological Association Journal
84. Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
    Hal Steven Farkas, Youn Hee Jee, Vivian L. Szymczuk, Ellen Leschek · 2024 · JCEM Case Reports
85. Fertilität bei Männern über 40 Jahren
    Michael Zitzmann · 2014 · Gynäkologische Endokrinologie
86. Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
    Velu Krishnan, Shivani S. Patel, Priyanka Shenoy, Jessica Ann Cottrell · 2023 · Middle East Fertility Society Journal
87. Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice
    César Daniel Villarreal‐Villarreal, Estefania Boland‐Rodríguez, Carolina Gonzalez-Macias, Juan Francisco Molina-de la Garza, David Saceda‐Corralo, Sérgio Vañó-Galván · 2025 · Journal of Aesthetic Medicine
88. Ameliorative Potential of Lycopene Against Finasteride-Induced Seminiferous Tubules Damage in Adult Rats: A Histological, Immunohistochemical, and Biochemical Study
    Amany Mohamed Shalaby, Hamad Alsaykhan, Sulaiman Mohammed Alnasser, Mohammed Alorini, Fatima A. Jaber, Mohamed Ali Alabiad, Mahmoud Ramadan Elkholy, Maha Ahmed Shehab · 2025 · Microscopy and Microanalysis
89. Paternal finasteride exposure and its impact on offspring testicular histopathology and intracellular junctions: the role of occludin and N-cadherin
    Marika Freus, Kamila Misiakiewicz-Has, Anna Pilutin, Karolina Podborączyńska‐Jodko, Aleksandra Wilk, Agnieszka Kolasa · 2026 · Reproductive Biology
90. Testosterone undecanoate in the functional compartments of the male reproductive tract
    Eftychia G. Koukkou, Georgios Mitios, Niki Kapolla, E. Spiropoulos, Holger Lass, Michael Bourounis, A. Pappa, Stamatina Nicopoulou, Dimitri A. Adamopoulos · 2009 · Basic and Clinical Andrology
91. Risks from Medical and Therapeutic Treatments
    Yagil Barazani, Edmund S. Sabanegh · 2014 · Springer eBooks
92. Finasteride and male infertility: a case for prospective collaborative research databases?
    James Morris Hotaling · 2013 · Fertility and Sterility
93. Adverse effects of environmental chemicals and drugs on the male reproductive system
    James V. Bruckner, David M. Fenig, Larry I. Lipshultz · 2009 · Cambridge University Press eBooks
94. Finasteride in Androgenic Alopecia
    Patrick M. Zito, Nady Hin · 2016 · Journal of the Dermatology Nurses’ Association
95. Systemic Therapies for Scarring and Non-scarring Alopecia
    Carolyn Goh · 2017 · Springer eBooks
96. Effectiveness of Testosterone Undecanoate Treatment in Men with Asthenospermia
    Bo SONG, Zhiming Cai · 2012 · Chin J Reprod Contracep
97. Alopecia androgénica
    M. Brunault · 2014 · EMC - Dermatología
98. Dutasteride
    Konstantinos Anastassakis · 2022 · Springer eBooks
99. Platelet-rich plasma
    Geraldine Cheyana Ranasinghe, Shilpi Khetarpal · 2023 · Elsevier eBooks
100. Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors
     Thomas Z. Rohan, Grace Turchetta, Sherry X. Yang · 2024 · Archives of Dermatological Research